About Deep Brain Stimulation
A neurostimulation system, also known as a neurostimulator, provides therapeutic activation or modulation in the nervous system at targeted anatomical sites. Deep brain stimulation (DBS) system, a type of neurostimulator, generates electrical stimulation to the targeted areas of the brain and regulates the electrical signals that are generated by the diseased brain cells and neurons.
Technavio’s analysts forecast the global DBS market to grow at a CAGR of 10.59% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global DBS market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various types of DBS systems.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Deep Brain Stimulation Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific Corp.
• Medtronic plc
• St. Jude Medical Inc.
Other prominent vendors
• Adaptive Neuromodulation
• Aleva Neurotherapeutics
• Beijing Pins Medical
• NeuroPace
• NeuroSigma
Market driver
• Increased number of market approvals
• For a full, detailed list, view our report
Market challenge
• High cost of DBS therapy
• For a full, detailed list, view our report
Market trend
• Hybrid neuroprosthetic devices
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Approved indications for DBS therapy
• History of DBS
PART 05: Potential applications of DBS
PART 06: Cost of DBS system components and implantation
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by application
• PD
• Dystonia
• OCD
• Epilepsy
PART 09: Geographical segmentation
• DBS market in Americas
• DBS market in EMEA
• DBS market in APAC
PART 10: Market drivers
• Increase in prevalence of neurological disorders
• Availability of funds and grants for R&D
• Increased number of market approvals
PART 11: Impact of drivers
PART 12: Market challenges
• High cost of DBS therapy
• Complications related to DBS
• High maintenance and low battery lifetime
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Hybrid neuroprosthetic devices
• Next-generation therapies for nervous system disorders
• Emergence of clinician programmer
PART 15: Vendor landscape
• Competitive scenario
• Market share analysis
PART 16: Key vendor analysis
• Boston Scientific
• Medtronic
• St. Jude Medical
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
?
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Neurological conditions and their symptoms treated by DBS therapy
Exhibit 03: History of DBS
Exhibit 04: Conditions under investigation for DBS therapy
Exhibit 05: Cost of DBS implantation and treatment
Exhibit 06: Cost difference between DBS and pharmacological and follow-up cost 2015
Exhibit 07: Cost breakdown of DBS components 2015
Exhibit 08: Cost breakdown of pharmacological and follow-up cost in DBS 2015
Exhibit 09: Adverse event cost (due to surgical error) of DBS implantation 2015
Exhibit 10: Global DBS market by revenue 2015-2020 ($ millions)
Exhibit 11: Five forces analysis
Exhibit 12: Global DBS market segmentation by application 2015
Exhibit 13: Global DBS market by application 2015
Exhibit 14: Global DBS market by geography 2015
Exhibit 15: Global DBS market by geography 2020
Exhibit 16: Conditions treated by DBS in the US
Exhibit 17: Economic burden of diseases in the US
Exhibit 18: DBS market in Americas 2015-2020 ($ millions)
Exhibit 19: Prevalence and financial burden of neurodegenerative diseases in Europe 2010
Exhibit 20: DBS market in EMEA 2015-2020 ($ millions)
Exhibit 21: DBS market in APAC 2015-2020 ($ millions)
Exhibit 22: Global DBS market by geography 2015-2020
Exhibit 23: Global DBS market by geography 2015-2020 ($ millions)
Exhibit 24: Research funding for DBS
Exhibit 25: Regulatory approvals for DBS System
Exhibit 26: Impact of drivers
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Boston Scientific: Product portfolio
Exhibit 29: Boston Scientific: Neuromodulation segment by revenue 2012-2014 ($ millions)
Exhibit 30: Boston Scientific: Key takeaways
Exhibit 31: Medtronic: Product portfolio
Exhibit 32: Medtronic: Neuromodulation segment by revenue 2013-2015 ($ billions)
Exhibit 33: Medtronic: Key takeaways
Exhibit 34: St. Jude Medical: Product portfolio
Exhibit 35: St. Jude Medical: Neuromodulation segment by revenue 2012-2014 ($ millions)
Exhibit 36: St. Jude Medical: Key takeaways
